BackgroundThe antibody pair labels B- and T-cell lymphoma, T- and B-cell leukaemia and may also be used for the characterization of malign lymphoma of the thyroid gland. Hairy cell leukaemia is also antibody positive, while myeloid (granulocytes) and erythroid tumours usually are negative. LCA, the human Leukocyte Common Antigen consists of a family of cell membrane glycoproteins with a molecular mass between 180 and 220 kDa. They are located on the surface of almost all leukocytes. The two clones included in the antibody cocktail have been characterized on theInternational Workshops on Human Leukocyte TypingIII and IV and have been assigned as CD45 and CD45RB respectively Cell membrane of lymphoid cells (macrophages and polymorph nuclear lymphocytes stain weakly, while plasma cells usually are negative).No reactivity with non-hematopoetic cells, epithelia and connective tissue..

Source

Immunogen: Activated and neoblastic T-cells

ProductAntibody solution in stabilizing phosphate buffer pH 7.3. Contains 0.09 % sodium azide**. The volume is sufficient for at least 100 immunohistochemical tests (100 µl working solution / test). Use appropriate antibody diluent e.g. BIOLOGOArt .No. PU002.

Purification Method: Antibody solution in stabilizing phosphate buffer pH 7.3. Contains 0.09 % sodium azide**. The volume is sufficient for at least 100 immunohistochemical tests (100 µl working solution / test). Use appropriate antibody diluent e.g. BIOLOGOArt .No. PU002.

Concentration: 30 µg/ml

Secondary Reagents: We recommend the use of BIOLOGO's Universal Staining System DAB (Art. No. DA005) or AEC (Art.-No. AE005).

Specificity

Species Reactivity: Human

ApplicationsIHC(P), FACS

Incubation Time: 60 min at RT

Working Concentration: (liquid conc.) 1:10-1:50

Pre-Treatment: No pre-treatment with proteases necessary, improved staining with unmasking fluid G (Art. No. DE007)

Positive Control: Tonsil

Storage2-8°C

CautionThis product is intended FOR RESEARCH USE ONLY, and FOR TESTS IN VITRO, not for use in diagnostic or therapeutic procedures involving humans or animals. It may contain hazardous ingredients. Please refer to the Safety Data Sheets (SDS) for additional information and proper handling procedures. Dispose product remainders according to local regulations.This datasheet is as accurate as reasonably achievable, but Nordic-MUbio​ accepts no liability for any inaccuracies or omissions in this information.

References1. Dalchau R., Kirkley J., and Fabre J.W. (1980) Monoclonal antibody to a human leukocyte-specific membrane glykoprotein probably homologous to the leukocyte-common (L-C) antigen of the rat. Europ. J. Immunol. 10; 737-744. 2. Streuli M., Morimoto C., Schrieber M., Schlossman S.F., and Saito H. (1988) Characterization of CD45 and CD45R monoclonal antibodies using transfected mouse cell lines that express individual human leukozyte common antigens. J. Immunology 141; 3910-3914 3. Pulido R., Cebrian M., Acevedo A., De Landazuri M.O., Sanchez-Madrid F. (1988) Comparative biochemical and tissue distribution study of four distinct CD45 antigen specificities. J. Immunol. 140; 3851-3857.

Safety Datasheet(s) for this product:NM_Sodium Azide/wp-content/uploads/SDS/Antibody SDS with Sodium Azide Noridic-MUbio.pdf